These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 3524050)

  • 21. Cold-adapted variants of influenza A virus: evaluation in adult seronegative volunteers of A/Scotland/840/74 and A/Victoria/3/75 cold-adapted recombinants derived from the cold-adapted A/Ann Arbor/6/60 strain.
    Murphy BR; Holley HP; Berquist EJ; Levine MM; Spring SB; Maassab HF; Kendal AP; Chanock RM
    Infect Immun; 1979 Feb; 23(2):253-9. PubMed ID: 422240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant cold-adapted attenuated influenza A vaccines for use in children: molecular genetic analysis of the cold-adapted donor and recombinants.
    Ghendon YZ; Polezhaev FI; Lisovskaya KV; Medvedeva TE; Alexandrova GI; Klimov AI
    Infect Immun; 1984 Jun; 44(3):730-3. PubMed ID: 6724694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trivalent attenuated cold-adapted influenza virus vaccine: reduced viral shedding and serum antibody responses in susceptible adults.
    Keitel WA; Couch RB; Quarles JM; Cate TR; Baxter B; Maassab HF
    J Infect Dis; 1993 Feb; 167(2):305-11. PubMed ID: 8421165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunization of infants and young children with live attenuated trivalent cold-recombinant influenza A H1N1, H3N2, and B vaccine.
    Belshe RB; Swierkosz EM; Anderson EL; Newman FK; Nugent SL; Maassab HF
    J Infect Dis; 1992 Apr; 165(4):727-32. PubMed ID: 1552202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Reactogenicity, genetic stability and effectiveness of a live recombinant influenza vaccine for children designed on the base of a cold-adapted attenuation donor A/Leningrad/134/47/57].
    Aleksandrova GI; Medvedeva TE; Polezhaev FI; Garmashova LM; Budilovskiĭ GN
    Vopr Virusol; 1986; 31(4):411-4. PubMed ID: 2945324
    [No Abstract]   [Full Text] [Related]  

  • 26. Simultaneous administration of live, attenuated influenza A vaccines representing different serotypes.
    Wright PF; Bhargava M; Johnson PR; Thompson J; Karzon DT
    Vaccine; 1985 Sep; 3(3):305-8. PubMed ID: 3904259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of yearly vaccinations with live, attenuated, cold-adapted, trivalent, intranasal influenza vaccines on antibody responses in children.
    Bernstein DI; Yan L; Treanor J; Mendelman PM; Belshe R;
    Pediatr Infect Dis J; 2003 Jan; 22(1):28-34. PubMed ID: 12544405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of live, cold-adapted influenza A and B virus vaccines in elderly and high-risk subjects.
    Treanor JJ; Betts RF
    Vaccine; 1998 Nov; 16(18):1756-60. PubMed ID: 9778752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies in man with cold-recombinant influenza virus (H1N1) live vaccines.
    Reeve P; Gerendas B; Moritz A; Liehl E; Kunz C; Hofmann H; Maassab HF
    J Med Virol; 1980; 6(1):75-83. PubMed ID: 7014783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Live attenuated and inactivated influenza vaccine in school-age children.
    Gruber WC; Taber LH; Glezen WP; Clover RD; Abell TD; Demmler RW; Couch RB
    Am J Dis Child; 1990 May; 144(5):595-600. PubMed ID: 2330929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine.
    Belshe RB; Gruber WC; Mendelman PM; Mehta HB; Mahmood K; Reisinger K; Treanor J; Zangwill K; Hayden FG; Bernstein DI; Kotloff K; King J; Piedra PA; Block SL; Yan L; Wolff M
    J Infect Dis; 2000 Mar; 181(3):1133-7. PubMed ID: 10720541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.
    Drugs R D; 2003; 4(5):312-9. PubMed ID: 12952502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of live attenuated cold-adapted and avian-human influenza A/Bethesda/85 (H3N2) reassortant virus vaccines in infants and children.
    Steinhoff MC; Halsey NA; Wilson MH; Burns BA; Samorodin RK; Fries LF; Murphy BR; Clements ML
    J Infect Dis; 1990 Aug; 162(2):394-401. PubMed ID: 2197335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and immunogenicity of a live-attenuated influenza vaccine blended and filled at two manufacturing facilities.
    Nolan T; Lee MS; Cordova JM; Cho I; Walker RE; August MJ; Larson S; Coelingh KL; Mendelman PM
    Vaccine; 2003 Mar; 21(11-12):1224-31. PubMed ID: 12559802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of influenza A/Hong Kong/123/77 (H1N1) ts-1A2 and cold-adapted recombinant viruses in seronegative adult volunteers.
    Murphy BR; Rennels MB; Douglas RG; Betts RF; Couch RB; Cate TR; Chanock RM; Kendal AP; Maassab HF; Suwanagool S; Sotman SB; Cisneros LA; Anthony WC; Nalin DR; Levine MM
    Infect Immun; 1980 Aug; 29(2):348-55. PubMed ID: 7216417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advantage of live attenuated cold-adapted influenza A virus over inactivated vaccine for A/Washington/80 (H3N2) wild-type virus infection.
    Clements ML; Betts RF; Murphy BR
    Lancet; 1984 Mar; 1(8379):705-8. PubMed ID: 6143042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Live influenza A/Victoria/75 (H3N2) virus vaccines: reactogenicity, immunogenicity, and protection against wild-type virus challenge.
    Cate TR; Couch RB
    Infect Immun; 1982 Oct; 38(1):141-6. PubMed ID: 7141686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation in children of cold-adapted influenza B live attenuated intranasal vaccine prepared by reassortment between wild-type B/Ann Arbor/1/86 and cold-adapted B/Leningrad/14/55 viruses.
    Obrosova-Serova NP; Slepushkin AN; Kendal AP; Harmon MW; Burtseva EI; Bebesheva NI; Beljaev AL; Lonskaja NI; Medvedeva TE; Egorov AY
    Vaccine; 1990 Feb; 8(1):57-60. PubMed ID: 2180233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunity to influenza A virus infection in young children: a comparison of natural infection, live cold-adapted vaccine, and inactivated vaccine.
    Johnson PR; Feldman S; Thompson JM; Mahoney JD; Wright PF
    J Infect Dis; 1986 Jul; 154(1):121-7. PubMed ID: 3711685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cold-recombinant influenza A/California/10/78 (H1N1) virus vaccine (CR-37) in seronegative children: infectivity and efficacy against investigational challenge.
    Belshe RB; Van Voris LP
    J Infect Dis; 1984 May; 149(5):735-40. PubMed ID: 6726003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.